AMA #77: Dietary fiber and health outcomes: real benefits, overhyped claims, and practical applications
Peter Attia
Nov 10, 2025
Episode description
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this "Ask Me Anything" (AMA) episode, Peter breaks down the science of dietary fiber, moving beyond the blanket advice to "eat more fiber" to uncover what it actually does in the body and where its benefits are truly supported by evidence. He explains how different types of fiber—soluble, insoluble, viscous, and fermentable—affect digestion, satiety, weight management, and glycemic control, and compares their impact to other, more potent metabolic tools. Peter also examines how certain fibers influence lipid metabolism and cardiovascular risk, evaluates the strength of evidence for fiber's role in colorectal cancer prevention, and highlights why some individuals may not tolerate specific fibers well. The discussion concludes with practical guidance on moving past generic fiber targets toward a more strategic and personalized approach that maximizes the true benefits of fiber.
If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #77 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.
We discuss:
Why it's time to re-examine the evidence behind dietary fiber recommendations [2:00];
Why it's hard to isolate fiber's true effects on health: the limits of nutritional epidemiology [5:45];
Defining dietary fiber: what it is, how it's digested, and why different types have different effects [8:15];
Understanding fiber properties: how solubility, viscosity, and fermentability shape its effects in the body [11:15];
Resistant starches explained: types, food sources, and how cooking and cooling influence their benefits [16:30];
A fr
Mindsip insights from this episode:
More from
Peter Attia

#387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field

#386 - Aging clocks—what they measure, how they work, and their clinical and real-world relevance

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Women's health and performance: how training, nutrition, and hormones interact across life stages | Abbie Smith-Ryan, Ph.D.







